首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
PembrolizumabBullous rash: case report
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2021年
/ 1877卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-021-03895-1
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:325 / 325
相关论文
共 50 条
[31]
AmitriptyllineGeneralised rash: case report
Reactions Weekly,
2017,
1677
(1)
: 20
-
20
[32]
ParoxetineSkin rash: case report
Reactions Weekly,
2002,
905
(1)
: 10
-
10
[33]
PaliferminGeneralised rash: case report
Reactions Weekly,
2015,
1582
(1)
: 340
-
340
[34]
MirtazapineFacial rash: case report
Reactions Weekly,
2019,
1742
(1)
: 164
-
164
[35]
TelaprevirUrticarial rash: case report
Reactions Weekly,
2014,
1500
(1)
: 36
-
36
[36]
VedolizumabSkin rash: case report
Reactions Weekly,
2019,
1738
(1)
: 260
-
260
[37]
IndometacinSkin rash: case report
Reactions Weekly,
2018,
1687
(1)
: 114
-
114
[38]
AzathioprineSkin rash: case report
Reactions Weekly,
2019,
1770
(1)
: 72
-
72
[39]
ImatinibSkin rash: case report
Reactions Weekly,
2015,
1580
(1)
: 206
-
206
[40]
CetuximabAcneiform rash: case report
Reactions Weekly,
2014,
1483
(1)
: 31
-
31
←
1
2
3
4
5
→